Jacqueline Claire Lupo
Chief Executive Officer at LOPHOS HOLDINGS INC.
Net worth: 440 000 $ as of 2024-05-30
Jacqueline Claire Lupo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LOPHOS HOLDINGS INC. | Director/Board Member | 2021-12-22 | - |
| Chief Executive Officer | 2021-12-22 | - | |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Director/Board Member | 2020-12-31 | - |
| Chief Executive Officer | 2021-08-31 | - | |
| Founder | 2020-12-31 | - | |
| President | 2021-08-31 | - | |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - | - |
Career history of Jacqueline Claire Lupo
Former positions of Jacqueline Claire Lupo
| Companies | Position | Start | End |
|---|---|---|---|
| Canalytica Corp. | Founder | - | - |
Statistics
International
| Canada | 4 |
| 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
| Lophos Holdings, Inc. | |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
